Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation

Despite the substantial advances in the management of metastatic melanoma with the introduction of immune checkpoint inhibitors (ICI), many patients develop disease progression during treatment with immunotherapy. This has been suggested to be mediated by several mechanisms that contribute to acquir...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Khaddour, Karam, Dowling, Joshua, Huang, Jiayi, Council, Martha, Chen, David, Cornelius, Lynn, Johanns, Tanner, Dahiya, Sonika, Ansstas, George
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2020
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7779252/
https://ncbi.nlm.nih.gov/pubmed/33447351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27848
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares